This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Individuals (male or female) aged 20 years or older
Willing and able to provide written informed consent to participate in the study
Pregnant or breastfeeding women
Patients with end-stage renal disease receiving hemodialysis or peritoneal dialysis
Individuals currently undergoing active cancer treatment
Recipients of any organ transplantation